Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  mitomycin C
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 366 for your search:
Start Over
Topical Interferon Alfa 2b and Mitomycin C in Conjunctival-Corneal Intraepithelial Neoplasia
Phase: Phase IV
Type: Treatment
Status: Closed
Age: 18 to 90
Sponsor: Other
Protocol IDs: R-2012-785-094, NCT02199327
Phase II-III FAM (5-FU/ADR/MITO) vs V-FAM (FAM/VCR) vs Phase II Agent Chemotherapy for Advanced Gastric Adenocarcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7841
Phase II/III Comparison of FAM (5-FU/ADR/MITO) vs Sequential MITO, ADR, and 5-FU for Hormone-Refractory Carcinoma of the Prostate (Summary last modified 06/97)
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCCTG-825251, NCCTG-82-52-51
Phase III Chemotherapy with FAM-S (5-FU/ADR/MITO/SZC) vs a Phase II Drug for Locally Inoperable or Metastatic Pancreatic Adenocarcinoma, a Master Protocol
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 70
Sponsor: NCI
Protocol IDs: SWOG-8040
Phase II/III Randomized Comparison of PF (CACP/5-FU) vs MVPF (MITO/VCR/CACP/5-FU) in Advanced Large Bowel Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1285
Phase II/III Randomized Trial of Immunotherapy with MoAb 17-1A Given Before vs After Chemotherapy with FAM (5-FU/ADR/MITO-C) in Patients with Advanced Pancreatic Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: FCCC-85719, NCI-V85-0077
Phase II/III Study of Intravesical Chemotherapy with Mitomycin-C in Patients with Multiple Lesions of Superficial Bladder Cancer (Summary Last Modified 06/88)
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 85 and under
Sponsor:
Protocol IDs: EORTC-30864
Phase II/III Chemotherapy with Combinations of MeCCNU, MITO, ADR and 5-FU for Advanced Measurable Gastric Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2277
Phase II-III Study of Chemotherapy with ADR or 5-FU/MeCCNU or 5-FU/Mitomycin C for Advanced Gastric Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-3274, MAYO-706018
Adriamycin Chemotherapy versus 5-FU/MeCCNU/ADR or 5-FU/MITO/ARA-C for Advanced Gastric Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: GITSG-8375
Phase II-III Study with 5-FU/ICRF-159/MeCCNU, 5-FU/ADR with or without MITO or MeCCNU, and 5-FU/MeCCNU for Unresectable Gastric Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: GITSG-8376, MAYO-764101
Phase II-III Combination Chemotherapy with 5-FU/ADR with or without MeCCNU or MITO for Unresectable Gastric Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: GITSG-8376R
The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: AG0501CR, NCT00294359
Efficacy of Distilled Water Versus Mitomycin C on Preventing Recurrences of Bladder Cancer After Transurethral Resection
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: Other
Protocol IDs: URO-DW-1971, NCT00816075
Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 12154, NCT01438112
Phase III Randomized Study of Radiotherapy with vs without BLEO/MITO/CDDP/VP-16 for Locally Advanced Squamous Cell Carcinoma of the Cervix (Summary Last Modified 08/94)
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 75
Sponsor:
Protocol IDs: FRE-FNCLCC-CO-II, NCI-F94-0020
Phase III Randomized Study of Surgery with or without Intraportal 5-FU/MITO Followed by 5-FU/LEV with or without CF in Stage II/III Colorectal Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 75
Sponsor:
Protocol IDs: BEL-GRECR-B, EU-96001
Start Over